UK / Pharma Industry Warns of Declining Competitiveness
The UK government has decided to go ahead with a much-debated increase in the revenue clawback rate —from 24.4 percent to 27.5 percent— for drugmakers subject to its Statutory Scheme…
Address: 13 Windsor Street, Islington, London N1 8QG,United Kingdom
Tel: +44(0)20 7288 7008
An elegant corporate events venue for business meetings & private conferences in Islington, London.
Many clients comment on how well their functions turn out at The Window. The combination of the light, spacious ambience and the friendly, responsive events team, allows clients to step out of the ordinary “conference mode” and encourages creative thinking and open dialogue.
Whether it’s for a business conference, a product launch, training seminar or executive meeting, the flexible floor spaces add that extra imaginative flair and the personalised client service takes care of the details to ensure an event is a complete success.
Venu hire for corporate events or private events.
The Window offers four distinctive and complementary floor spaces with eight rooms to suit varying needs. The elegant entrance way, flanked by a rock garden and over-hanging balcony, welcomes clients into a light and spacious two tiered reception floor.
The top floor conference room provides the focal point for the event. Its panoramic view of the London skyline and trade mark 12ft window make this an impressive backdrop for corporate presentations. Third floor executive suite and meeting rooms are ideal for smaller meetings and presentations. Audio Visual Services are also available on request.
The dining area, supported by specialist in-house catering services, can also be used as a secondary conference floor. Its more informal and relaxed environment lends itself to break out groups, private meetings and informal gatherings. Additional private rooms are also available upon request.
The Window’s prime location is supported by good transport links with Angel and Highbury & Islington underground stations and an NCP car park, all within a 10 minute walk. Wheelchair access is provided to all floors and The Hilton Hotel is close by for delegates requiring overnight accommodation.
The UK government has decided to go ahead with a much-debated increase in the revenue clawback rate —from 24.4 percent to 27.5 percent— for drugmakers subject to its Statutory Scheme…
Dr Matt Linley, senior director for analytics and forecasting at predictive health analytics firm Airfinity, looks ahead to a potentially game-changing year in the fight against respiratory synctial virus (RSV),…
A roundup of the latest UK healthcare, pharma and biotech news including AbbVie and Lilly’s departure from the country’s voluntary medicines pricing agreement, Moderna’s expanded footprint, UK biotech’s 2022 funding…
What digital skills do pharma leaders need in order to drive transformation, deliver success at scale in the business, and prepare for next-gen customer engagement? Sarah Gilchriest explores the critical…
Bernard Ross, a serial entrepreneur with more than 20 years’ senior experience at private and public board level across multiple industries, looks ahead to 2023 and highlights five key trends…
After an almost 20-year career in Big Pharma culminating in a role as president of AstraZeneca UK, Lisa Anson took the leap into the biotech world to lead what at…
Pricing and market access have become increasingly hot topics in recent years, as healthcare systems across the world attempt to balance their own financial sustainability with securing the latest medical…
National Health Service (NHS) England CEO Amanda Pritchard has raised concerns about the state of British healthcare in recent weeks and months, proclaiming that the NHS is in a worse…
With the brief tenure of Liz Truss as Prime Minister already drawing to a close, the UK faces yet another new leader as the country attempts to extricate itself from…
“Life sciences are at the heart of my vision to build a country fit for the future,” tweeted new UK Prime Minister Liz Truss last month. Now installed as leader…
US biotech Moderna – producer of a messenger RNA (mRNA) COVID-19 vaccine that has found its way into 75 million arms in the US alone and generated USD 12 billion…
After several scandals that revealed longstanding deficiencies and a continual churn of executive staff, a recent independent review of leadership in the National Health Service (NHS) has uncovered a lack…
See our Cookie Privacy Policy Here